Product category:
Genomics
News Release from: Dynal Biotech | Subject: Dynabeads Tcap
Edited by the Laboratorytalk Editorial
Team on 08 December 2004
Isolate antigen-specific CD8+ T cells
System will benefit in vitro investigation of T cell functions and research into adoptive T cell immunotherapy
Dynal Biotech has launched an innovative new range of easy-to-use products called Dynabeads Tcap This is said to be the only ready-to-use system to use proven magnetic bead technology to isolate a high yield of antigen-specific CD8+ T cells
This article was originally published on Laboratorytalk on 8 Nov 2004 at 8.00am (UK)
Related stories
Rapid and automated isolation of mRNA
Platform for gene-expression studies is based on superparamagnetic separation technologies, and can consistently isolate poly A+ mRNA with or without prior total RNA preparation
It will benefit in vitro investigation of T cell functions and research into adoptive T cell immunotherapy.
Dynabeads Tcap for Epstein Barr virus, cytomegalovirus and a range of cancer antigens are available now - the range will be further developed in the coming year.
Dynabeads Tcap are coupled with recombinant HLA-A*0201 molecules loaded with specific peptides which are recognised by CD8+ T cells.
After a short, tube-based incubation with Dynabeads Tcap, antigen specific CD8+ T cells are captured and isolated with a magnet.
The process is quick, reliable and efficient.
The isolated cells are pure and viable and can be expanded in culture.
Dynabeads are monosized, superparamagnetic microbeads that are coated with a variety of ligands, depending on the target of interest.
The beads bind to the target of interest and when a magnet is applied, the bead-target complex moves towards the magnet.
This proven technology is widely used in cell biology, immunology, molecular biology and microbiology.
• Dynal Biotech: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page

